Elutia Inc. financial data

Symbol
ELUT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
12510 Prosperity Drive, Suite 370, Silver Spring, Maryland
State of incorporation
Delaware
Fiscal year end
December 31
Former names
AZIYO BIOLOGICS, INC. (to 8/14/2023)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 77.4 % -28.7%
Quick Ratio 13.4 % -39.3%
Debt-to-equity -232 % +75.1%
Return On Equity 136 % -69.7%
Return On Assets -103 % -90.9%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 15M USD -51.8%
Weighted Average Number of Shares Outstanding, Basic 23.9M shares +48.1%
Weighted Average Number of Shares Outstanding, Diluted 23.9M shares +48.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.98M USD -43.5%
Selling and Marketing Expense 11.7M USD -34%
General and Administrative Expense 15.6M USD +0.61%
Operating Income (Loss) -30.7M USD +16.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -49.4M USD -30.9%
Income Tax Expense (Benefit) 24K USD -29.4%
Net Income (Loss) Attributable to Parent -47.7M USD -45.7%
Earnings Per Share, Basic -2.33 USD/shares -2.64%
Earnings Per Share, Diluted -2.33 USD/shares -2.64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.6M USD +6.46%
Accounts Receivable, after Allowance for Credit Loss, Current 4.41M USD -39.9%
Inventory, Net 3.05M USD -72.4%
Assets, Current 24M USD -44.8%
Property, Plant and Equipment, Net 171K USD -88.5%
Operating Lease, Right-of-Use Asset 271K USD +19.9%
Intangible Assets, Net (Excluding Goodwill) 10.8M USD -23.9%
Other Assets, Noncurrent 383K USD -73.7%
Assets 35.4M USD -41.7%
Accounts Payable, Current 4.16M USD +18.8%
Accrued Liabilities, Current 9.02M USD -3.43%
Liabilities, Current 38.1M USD -8.1%
Operating Lease, Liability, Noncurrent 711K USD
Other Liabilities, Noncurrent 694K USD +235%
Liabilities 85.7M USD +17.7%
Retained Earnings (Accumulated Deficit) -194M USD -32.7%
Stockholders' Equity Attributable to Parent -50.3M USD -313%
Liabilities and Equity 35.4M USD -41.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.64M USD +48.9%
Net Cash Provided by (Used in) Financing Activities -4.07M USD -2849%
Net Cash Provided by (Used in) Investing Activities -15K USD +91.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.6M USD +6.46%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.54M USD +344%
Deferred Tax Assets, Valuation Allowance 39M USD +22.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 39.5M USD +20.6%
Operating Lease, Liability 275K USD +18.5%
Depreciation 100K USD 0%
Payments to Acquire Property, Plant, and Equipment 15K USD -91.8%
Lessee, Operating Lease, Liability, to be Paid 281K USD +18.6%
Property, Plant and Equipment, Gross 753K USD -9.28%
Operating Lease, Liability, Current 275K USD +18.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 554K USD -44.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 281K USD +18.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD +20%
Lessee, Operating Lease, Liability, to be Paid, Year Three 470K USD -39.8%
Deferred Tax Assets, Operating Loss Carryforwards 23.3M USD +18.1%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 600K USD +50%
Additional Paid in Capital 143M USD +7.14%
Amortization of Intangible Assets 3.4M USD +0.03%
Depreciation, Depletion and Amortization 864K USD -8.77%
Share-based Payment Arrangement, Expense 3.95M USD +29.4%
Interest Expense 5.68M USD +6.49%